Population of PAH patients
Variable . | Dana point classification . | Age, y . | Sex . | Race . | Mutation . |
---|---|---|---|---|---|
Idiopathic PAH | |||||
1 | 1.1 | 61 | Female | White | None identified |
2 | 1.1 | 54 | Female | White | None identified |
Familial PAH | |||||
Family 1 | 1.2.1 | 38 | Female | White | BMPR2 c.2580delT |
Family 1 | 1.2.1 | 40 | Male | White | BMPR2 c.2580delT |
Family 2 | 1.2.3 | 54 | Female | White | None identified |
Family 2 | 1.2.3 | 28 | Female | White | None identified |
Family 2 | 1.2.3 | 53 | Female | White | None identified |
Family 3 | 1.2.1 | 55 | Female | White | BMPR2 Exon-3 deletion |
Family 6 | 1.2 | 22 | Male | White | Caveolin-1 |
Family 6 | 1.2 | 43 | Female | White | Caveolin-1 |
Family 6 | 1.2 | 68 | Male | White | Caveolin-1 |
Family 6 | 1.2 | 45 | Female | White | Caveolin-1 |
Family 7 | 1.2.1 | 40 | Female | White | BMPR2 C.189_209del21 |
Variable . | Dana point classification . | Age, y . | Sex . | Race . | Mutation . |
---|---|---|---|---|---|
Idiopathic PAH | |||||
1 | 1.1 | 61 | Female | White | None identified |
2 | 1.1 | 54 | Female | White | None identified |
Familial PAH | |||||
Family 1 | 1.2.1 | 38 | Female | White | BMPR2 c.2580delT |
Family 1 | 1.2.1 | 40 | Male | White | BMPR2 c.2580delT |
Family 2 | 1.2.3 | 54 | Female | White | None identified |
Family 2 | 1.2.3 | 28 | Female | White | None identified |
Family 2 | 1.2.3 | 53 | Female | White | None identified |
Family 3 | 1.2.1 | 55 | Female | White | BMPR2 Exon-3 deletion |
Family 6 | 1.2 | 22 | Male | White | Caveolin-1 |
Family 6 | 1.2 | 43 | Female | White | Caveolin-1 |
Family 6 | 1.2 | 68 | Male | White | Caveolin-1 |
Family 6 | 1.2 | 45 | Female | White | Caveolin-1 |
Family 7 | 1.2.1 | 40 | Female | White | BMPR2 C.189_209del21 |